Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.

BACKGROUND: Melioidosis, an infectious disease caused by the Gram-negative bacillus Burkholderia pseudomallei, is difficult to cure. Antimicrobial treatment comprises intravenous drugs for at least 10 days, followed by oral drugs for at least 12 weeks. The standard oral regimen based on trial eviden...

Full description

Bibliographic Details
Main Authors:	Chetchotisakd, P, Chierakul, W, Chaowagul, W, Anunnatsiri, S, Phimda, K, Mootsikapun, P, Chaisuksant, S, Pilaikul, J, Thinkhamrop, B, Phiphitaporn, S, Susaengrat, W, Toondee, C, Wongrattanacheewin, S, Wuthiekanun, V, Chantratita, N, Thaipadungpanit, J, Day, N, Limmathurotsakul, D, Peacock, S
Format:	Journal article
Language:	English
Published:	2014

Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.

Similar Items